Dual PROTACs Close In on Two Disease Proteins at Once
A new review in Molecular Diversity charts the rapid rise of dual PROTACs, single molecules engineered to destroy two disease-driving ...
A new review in Molecular Diversity charts the rapid rise of dual PROTACs, single molecules engineered to destroy two disease-driving ...
A drug already celebrated in cancer research circles for its ability to sabotage a cellular tagging system has now revealed ...
Dana-Farber Cancer Institute researchers have developed a systematic platform for discovering molecular glue degraders, a class of drug-like compounds that ...
In the ever-evolving landscape of microbial pathogenesis, the intricate mechanisms by which bacterial pathogens manipulate host cells remain a captivating ...
Huntington's disease remains a devastating neurodegenerative disorder marked by relentless progression and a grave prognosis. At the heart of this ...
In a breakthrough that promises to redefine the landscape of targeted protein degradation, researchers have unveiled a novel class of ...
In the ever-evolving landscape of biomedical research, targeted protein degradation has emerged as a promising frontier in therapeutic development. This ...
A groundbreaking study has unveiled a critical molecular mechanism propelling the progression of non-alcoholic fatty liver disease (NAFLD), one of ...
The persistent overexpression of the lysine-specific demethylase 1 (LSD1) enzyme has been notoriously linked to poor clinical outcomes across a ...
In the rapidly evolving landscape of cancer research, a new frontier has emerged that sheds light on the critical role ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine